#1 Clinical Trials Search in Europe

Chlorphenamine

Chlorphenamine, also known as chlorpheniramine, is an antihistamine medication that has been the subject of several clinical trials. These studies aim to evaluate its effectiveness in treating various conditions, including allergic reactions, seasonal allergic rhinitis, and even as a potential treatment for COVID-19 symptoms. The trials explore different formulations and applications of chlorphenamine, providing valuable insights into its safety and efficacy.

Table of Contents

What is Chlorphenamine?

Chlorphenamine, also known as chlorpheniramine, is a widely used antihistamine medication. Antihistamines are drugs that help reduce or block the effects of histamine, a substance your body produces during allergic reactions. Chlorphenamine belongs to the first-generation antihistamines, which means it may cause drowsiness as a side effect[1].

This medication is available under various brand names and formulations. Some common synonyms or brand names include:

  • Chlorpheniramine maleate
  • Chlorpheniramine tannate
  • AHIST
  • Tussionex® Pennkinetic® (when combined with hydrocodone)
  • ClorNovir® (as a nasal spray)[2][3][4]

Uses of Chlorphenamine

Chlorphenamine is primarily used to treat various allergic conditions. Its main uses include:

  • Seasonal Allergic Rhinitis: Also known as hay fever, this condition causes symptoms like sneezing, runny nose, and itchy eyes during specific seasons[1].
  • Allergic Reactions: It can help manage symptoms of general allergic reactions[2].
  • Allergic Transfusion Reactions: Some studies are investigating its use in preventing allergic reactions during blood transfusions[5].
  • Inflammatory Skin Diseases: Research is being conducted on its potential use in treating certain skin conditions[6].
  • COVID-19 Symptoms: Recent studies are exploring its potential in managing some symptoms of COVID-19, particularly when used as a nasal spray[4].

How Chlorphenamine Works

Chlorphenamine works by blocking the effects of histamine in your body. Histamine is a chemical your immune system produces when it detects something harmful, like an allergen. While histamine is important for your body’s defense, it can also cause uncomfortable allergy symptoms.

By blocking histamine, chlorphenamine helps reduce symptoms such as:

  • Sneezing
  • Runny nose
  • Itchy or watery eyes
  • Nasal congestion
  • Itchy skin or hives[1][3]

Forms and Dosages

Chlorphenamine comes in various forms and dosages, depending on the specific condition being treated and the patient’s age. Common forms include:

  • Oral tablets: Usually containing 4 mg of chlorphenamine maleate[7].
  • Extended-release capsules: These provide a longer-lasting effect and may contain chlorphenamine polistirex, which is equivalent to 8 mg of chlorphenamine maleate[8].
  • Oral suspension: Often combined with other medications like hydrocodone for cough relief[8].
  • Nasal spray: A newer form being studied, particularly for COVID-19 symptoms[4].

The dosage can vary widely depending on the form and the condition being treated. Always follow your doctor’s instructions or the package directions carefully.

Side Effects and Safety

While chlorphenamine is generally considered safe when used as directed, it can cause side effects. The most common side effect is drowsiness, which is why it’s often used in nighttime cold and allergy medications[1].

Other potential side effects may include:

  • Dry mouth
  • Blurred vision
  • Dizziness
  • Constipation
  • Difficulty urinating

In rare cases, more serious side effects can occur. Always consult your doctor if you experience any unusual or severe reactions.

Chlorphenamine is considered safe for most adults and children over 12 years old. However, it should be used with caution in certain groups, including pregnant women, people with certain medical conditions, and those taking other medications[6].

Ongoing Research

Researchers continue to explore new uses and formulations of chlorphenamine. Some areas of current research include:

  • COVID-19 Treatment: Studies are investigating whether chlorphenamine nasal spray (ClorNovir®) can help manage COVID-19 symptoms and speed up recovery[4].
  • Inflammatory Skin Diseases: Researchers are exploring the potential of local injections of chlorphenamine for treating chronic inflammatory skin conditions[6].
  • Allergic Transfusion Reactions: Studies are assessing whether chlorphenamine can help prevent allergic reactions during blood transfusions[5].

These ongoing studies may lead to new applications and improved formulations of chlorphenamine in the future, potentially offering more treatment options for patients with various conditions.

Aspect Details
Conditions Studied Seasonal allergic rhinitis, allergic transfusion reactions, inflammatory skin diseases, COVID-19 symptoms
Formulations Oral tablets, nasal sprays, intra-arterial injections, extended-release capsules
Age Groups Children, adolescents, and adults
Combination Therapies Studied with hydrocodone polistirex, compared with histamine antagonists and paracetamol
Key Outcomes Measured Pharmacokinetics, bioequivalence, symptom relief, safety and tolerability
Potential New Applications Treatment of COVID-19 symptoms, inflammatory skin diseases

FAQ

  • What conditions are being studied with chlorphenamine in clinical trials? Clinical trials are investigating chlorphenamine for various conditions, including seasonal allergic rhinitis, allergic transfusion reactions, inflammatory skin diseases, and as a potential treatment for COVID-19 symptoms.
  • How is chlorphenamine being administered in these trials? Chlorphenamine is being administered in various forms, including oral tablets, nasal sprays, intra-arterial injections, and extended-release formulations. The method of administration depends on the specific study and condition being treated.
  • Are there any studies looking at chlorphenamine for children? Yes, there is a study evaluating the pharmacokinetics of chlorphenamine maleate liquid in children and adolescents aged 2 to 18 years.
  • Is chlorphenamine being studied in combination with other drugs? Some trials are studying chlorphenamine in combination with other drugs. For example, one study is looking at a formulation that combines chlorphenamine polistirex with hydrocodone polistirex.
  • Are there any studies investigating chlorphenamine for COVID-19? Yes, there is a retrospective study evaluating the effectiveness of chlorphenamine maleate nasal spray (ClorNovir®) as part of the treatment for COVID-19 and its impact on clinical symptoms.

Ongoing Clinical Trials on Chlorphenamine

  • Study for Adults with Very High-Risk T-Cell Acute Lymphoblastic Leukemia Using Daratumumab and a Drug Combination

    Not recruiting

    1 1 1
    Investigated drugs:
    Italy

  • Study of LTX-315 and Pembrolizumab for Patients with Advanced Melanoma Resistant to PD-1/PD-L1 Therapy

    Not recruiting

    1 1 1
    Investigated drugs:
    France Norway Spain

Glossary

  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Bioequivalence: The absence of a significant difference in the rate and extent to which the active ingredient becomes available at the site of drug action when administered in the same dose under similar conditions.
  • Anaphylactoid reaction: A reaction that resembles anaphylaxis but does not involve an allergic mechanism. It can cause symptoms like flushing, rash, and a drop in blood pressure.
  • Tachyphylaxis: A rapid decrease in the response to a drug after repeated doses over a short period of time.
  • Allergic transfusion reaction: An adverse reaction to blood transfusion caused by an allergic response to components in the transfused blood.
  • Anosmia: The loss of the sense of smell.
  • Dysgeusia: An alteration in the perception of taste.
  • Rhinitis: Inflammation of the nasal passages, often causing symptoms such as sneezing, congestion, and runny nose.

References

  1. https://clinicaltrials.gov/study/NCT01008397
  2. https://clinicaltrials.gov/study/NCT00837837
  3. https://clinicaltrials.gov/study/NCT00853294
  4. https://clinicaltrials.gov/study/NCT05520944
  5. https://clinicaltrials.gov/study/NCT04688736
  6. https://clinicaltrials.gov/study/NCT04937101
  7. https://clinicaltrials.gov/study/NCT02722083
  8. https://clinicaltrials.gov/study/NCT00853190